Clinical Trial Update: Metformin Plus Megestrol Acetate As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating metformin plus megestrol acetate as a fertility-sparing treatment for atypical endometrial hyperplasia has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Endometrial Hyperplasia

Drugs mentioned

• Megestrol acetate (megestrol acetate)
• metformin (metformin)

Snippet

Sponsor: Fudan University | Conditions: Atypical Endometrial Hyperplasia | Phase 2, Phase 3 | Status: TERMINATED